232 related articles for article (PubMed ID: 17326061)
1. Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE).
Wessel TR; Arant CB; McGorray SP; Sharaf BL; Reis SE; Kerensky RA; von Mering GO; Smith KM; Pauly DF; Handberg EM; Mankad S; Olson MB; Johnson BD; Merz CN; Sopko G; Pepine CJ;
Clin Cardiol; 2007 Feb; 30(2):69-74. PubMed ID: 17326061
[TBL] [Abstract][Full Text] [Related]
2. Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study.
Pepine CJ; von Mering GO; Kerensky RA; Johnson BD; McGorray SP; Kelsey SF; Pohost G; Rogers WJ; Reis SE; Sopko G; Bairey Merz CN;
J Womens Health (Larchmt); 2007 May; 16(4):481-8. PubMed ID: 17521251
[TBL] [Abstract][Full Text] [Related]
3. Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study.
Handberg E; Johnson BD; Arant CB; Wessel TR; Kerensky RA; von Mering G; Olson MB; Reis SE; Shaw L; Bairey Merz CN; Sharaf BL; Sopko G; Pepine CJ
J Am Coll Cardiol; 2006 Feb; 47(3 Suppl):S44-9. PubMed ID: 16458171
[TBL] [Abstract][Full Text] [Related]
4. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
[TBL] [Abstract][Full Text] [Related]
5. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.
Wei J; Mehta PK; Johnson BD; Samuels B; Kar S; Anderson RD; Azarbal B; Petersen J; Sharaf B; Handberg E; Shufelt C; Kothawade K; Sopko G; Lerman A; Shaw L; Kelsey SF; Pepine CJ; Merz CN
JACC Cardiovasc Interv; 2012 Jun; 5(6):646-53. PubMed ID: 22721660
[TBL] [Abstract][Full Text] [Related]
6. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.
Reis SE; Holubkov R; Conrad Smith AJ; Kelsey SF; Sharaf BL; Reichek N; Rogers WJ; Merz CN; Sopko G; Pepine CJ;
Am Heart J; 2001 May; 141(5):735-41. PubMed ID: 11320360
[TBL] [Abstract][Full Text] [Related]
7. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
von Mering GO; Arant CB; Wessel TR; McGorray SP; Bairey Merz CN; Sharaf BL; Smith KM; Olson MB; Johnson BD; Sopko G; Handberg E; Pepine CJ; Kerensky RA;
Circulation; 2004 Feb; 109(6):722-5. PubMed ID: 14970106
[TBL] [Abstract][Full Text] [Related]
8. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.
Reis SE; Holubkov R; Lee JS; Sharaf B; Reichek N; Rogers WJ; Walsh EG; Fuisz AR; Kerensky R; Detre KM; Sopko G; Pepine CJ
J Am Coll Cardiol; 1999 May; 33(6):1469-75. PubMed ID: 10334410
[TBL] [Abstract][Full Text] [Related]
9. Coronary flow reserve is reduced in sarcoidosis.
Kul S; Kutlu GA; Guvenc TS; Kavas M; Demircioglu K; Yilmaz Y; Yakar HI; Kanbay A; Boga S; Caliskan M
Atherosclerosis; 2017 Sep; 264():115-121. PubMed ID: 28526473
[TBL] [Abstract][Full Text] [Related]
10. Comparison of low and high dose intracoronary adenosine and acetylcholine in women undergoing coronary reactivity testing: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Petersen JW; Mehta PK; Kenkre TS; Anderson RD; Johnson BD; Shufelt C; Samuels B; Kar S; Azarbal B; Handberg E; Kothawade K; Pepine CJ; Merz CN
Int J Cardiol; 2014; 172(1):e114-5. PubMed ID: 24461979
[No Abstract] [Full Text] [Related]
11. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study.
Park K; Quesada O; Cook-Wiens G; Wei J; Minissian M; Handberg EM; Merz NB; Pepine CJ
J Womens Health (Larchmt); 2020 Apr; 29(4):487-492. PubMed ID: 31859580
[No Abstract] [Full Text] [Related]
12. Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).
Anderson RD; Petersen JW; Mehta PK; Wei J; Johnson BD; Handberg EM; Kar S; Samuels B; Azarbal B; Kothawade K; Kelsey SF; Sharaf B; Shaw LJ; Sopko G; Bairey Merz CN; Pepine CJ
J Interv Cardiol; 2019; 2019():7169275. PubMed ID: 31772544
[TBL] [Abstract][Full Text] [Related]
13. Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD).
Mekonnen G; Hayek SS; Mehta PK; Li Q; Mahar E; Mou L; Kenkre TS; Petersen JW; Azarbal B; Samuels B; Anderson RD; Sedlak T; Zaya M; Agarwal M; Haftbaradaran A; Minissian M; Handberg E; Pepine CJ; Cogle CR; Bairey Merz CN; Waller EK; Quyyumi AA
Atherosclerosis; 2016 Oct; 253():111-117. PubMed ID: 27596135
[TBL] [Abstract][Full Text] [Related]
14. Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
Denardo SJ; Wen X; Handberg EM; Bairey Merz CN; Sopko GS; Cooper-Dehoff RM; Pepine CJ
Clin Cardiol; 2011 Aug; 34(8):483-7. PubMed ID: 21780138
[TBL] [Abstract][Full Text] [Related]
15. Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation.
Barsky L; Merz CNB; Wei J; Shufelt C; Handberg E; Pepine C; Rutledge T; Reis S; Doyle M; Rogers W; Shaw L; Sopko G
Curr Atheroscler Rep; 2020 Jun; 22(8):35. PubMed ID: 32556630
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Endothelial Function and Coronary Flow Velocity Reserve Are Not Associated in Women with Angina and No Obstructive Coronary Artery Disease: The iPOWER Study.
Flintholm Raft K; Frestad D; Michelsen MM; Suhrs HE; Rask AB; Nilsson M; Hermann TS; Prescott E
J Vasc Res; 2017; 54(5):309-319. PubMed ID: 28942444
[TBL] [Abstract][Full Text] [Related]
17. Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Mohandas R; Sautina L; Li S; Wen X; Huo T; Handberg E; Chi YY; Merz CN; Pepine CJ; Segal MS
PLoS One; 2013; 8(12):e81595. PubMed ID: 24312563
[TBL] [Abstract][Full Text] [Related]
18. Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation.
Thomson LE; Wei J; Agarwal M; Haft-Baradaran A; Shufelt C; Mehta PK; Gill EB; Johnson BD; Kenkre T; Handberg EM; Li D; Sharif B; Berman DS; Petersen JW; Pepine CJ; Bairey Merz CN
Circ Cardiovasc Imaging; 2015 Apr; 8(4):. PubMed ID: 25801710
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Reactive Hyperemia Index and Coronary Microvascular Function in Women With no Obstructive CAD: The iPOWER Study.
Michelsen MM; Mygind ND; Pena A; Aziz A; Frestad D; Høst N; Prescott E;
JACC Cardiovasc Imaging; 2016 Apr; 9(4):411-7. PubMed ID: 27056160
[TBL] [Abstract][Full Text] [Related]
20. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
